Protocol summary

Study aim
Determining the effect of synbiotics on reducing insulin resistance in overweight or obese children
Design
A clinical trial with parallel groups, double-blinded, randomized (permuted block randomization), phase 3 on 40 children with obesity/overweight, using www.sealedenvelope.com for randomization.
Settings and conduct
This study is performed in Ali Asghar Children's Hospital. Obese or overweight children are randomly assigned into two groups. In the first group, children receive Synbiotic. In the second group, children receive placebo. In this study, children and physicians did not know the type of medication they received.
Participants/Inclusion and exclusion criteria
Inclusion criteria: Age range between 4 -18 years, Obese or overweight children: Obese children, children with a BMI of more than 95% and overweight children, children with a BMI between 85-95%, Children with insulin resistance (HOMA-IR : > 2.5 = Positive for IR) Exclusion criteria: Children who developed obesity following syndromic disorder or endocrine disorders, Physical disability, Taking corticosteroids, Treated with metformin, Under special treatment or diet, Acute pancreatitis, History of allergies.
Intervention groups
In the intervention group, Children receive 1 sachet of probiotic daily (Kidi Lact, manufactured by Zist Takhmir Company, Iran) for 8 weeks. in the Control group: Children received one placebo sachet (manufactured by Zist Takhmir Company, Iran) daily for 8 weeks.
Main outcome variables
Insulin Resistance level

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20211226053529N1
Registration date: 2021-12-31, 1400/10/10
Registration timing: registered_while_recruiting

Last update: 2021-12-31, 1400/10/10
Update count: 0
Registration date
2021-12-31, 1400/10/10
Registrant information
Name
Farzaneh Rohani
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 2304 6253
Email address
rohani.f@iums.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2021-12-22, 1400/10/01
Expected recruitment end date
2022-04-19, 1401/01/30
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
The effect of Synbiotic on reducing insulin resistance in overweight or obese children
Public title
Effect of Synbiotic on reducing insulin resistance in overweight or obese children
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Age range between 4 -18 years Obese or overweight children: Obese children, children with a BMI of more than 95% and overweight children, children with a BMI between 85-95% Children with insulin resistance (HOMA-IR : > 2.5 = Positive for IR)
Exclusion criteria:
Children who developed obesity following synromic disorder or endocrine disorders Physical disability Taking corticosteroids Treated with metformin Under special treatment or diet Acute pancreatitis History of allergies
Age
From 4 years old to 18 years old
Gender
Both
Phase
3
Groups that have been masked
  • Participant
  • Care provider
  • Investigator
Sample size
Target sample size: 40
Randomization (investigator's opinion)
Randomized
Randomization description
In this study, the block randomization method is used with blocks of sizes six and four. The website https://www.sealedenvelope.com is used to create a randomization sequence. Each random sequence generated contains a unique code for concealment. The drug regimen is placed in envelopes according to random sequence, and after sealing it on the envelopes, the specific number created by the site is written and the envelopes are randomly placed in a box.
Blinding (investigator's opinion)
Double blinded
Blinding description
This study is double-blinded: both the patient and the doctor are unaware of the type of medication. Method of blinding patients: Synbiotic supplement is in the form of sachets, placebo sachets are exactly similar to the appearance, taste and smell of Kidi Lact and (produced by Zist Takhmir Company). Physician blinding method: sealed envelopes created by the Company are provided to a researcher who does not interfere in choosing the type of drug. After entering the study and collecting their baseline information from the physician, the individuals send them to the researcher to get the medicine, and the researcher will give one of the envelopes to the patients, and then in the sheet that is kept with the researcher, it is specified that What medicine has each patient taken.
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Iran University of Medical Sciences
Street address
Hemmat Highway, Next to the Milad Tower
City
Tehran
Province
Tehran
Postal code
۱۴۴۹۶۱۴۵۳۵
Approval date
2021-11-21, 1400/08/30
Ethics committee reference number
IR.IUMS.FMD.REC.1400.489

Health conditions studied

1

Description of health condition studied
Obesity
ICD-10 code
E66
ICD-10 code description
Overweight and obesity

Primary outcomes

1

Description
Insulin Resistance level
Timepoint
Before intervention and 8 weeks after intervention
Method of measurement
HOMA-IR.Index (µU/ml)

Secondary outcomes

empty

Intervention groups

1

Description
Intervention group: Children receive 1 sachet of probiotic daily (Kidi Lact, manufactured by Zist Takhmir Company, Iran) for 8 weeks.
Category
Treatment - Drugs

2

Description
Control group: Children received one placebo sachet (manufactured by Zist Takhmir Company, Iran) daily for 8 weeks.
Category
Placebo

Recruitment centers

1

Recruitment center
Name of recruitment center
Aliasghar Children's Hospital
Full name of responsible person
Rana Droudian
Street address
No.193, Zafar St, Modares Highway,
City
Tehran
Province
Tehran
Postal code
1919816766
Phone
+98 21 2304 6253
Email
dr.r.doroudian@gmail.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Hosein Keivani
Street address
Shahid Hemmat Highway next to the Milad tower
City
Tehran
Province
Tehran
Postal code
۱۴۴۹۶۱۴۵۳۵
Phone
+98 21 86701
Email
keivani.h@iums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
No
Title of funding source
Iran University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Rana Drodian
Position
Fellow
Latest degree
Specialist
Other areas of specialty/work
Pediatrics
Street address
Zafar st, Aliasghar Children's Hospital
City
Tehran
Province
Tehran
Postal code
1919816766
Phone
+98 21 2304 6253
Fax
Email
rohani.f@iums.ac.ir

Person responsible for scientific inquiries

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Rana Drodian
Position
Fellow
Latest degree
Specialist
Other areas of specialty/work
Pediatrics
Street address
Zafar st, Aliasghar Children's Hospital
City
Tehran
Province
Tehran
Postal code
1919816766
Phone
+98 21 2304 6253
Fax
Email
dr.r.doroudian@gmail.com

Person responsible for updating data

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Rana Drodian
Position
Fellow
Latest degree
Specialist
Other areas of specialty/work
Pediatrics
Street address
Zafar st, Aliasghar Children's Hospital
City
Tehran
Province
Tehran
Postal code
1919816766
Phone
+98 21 2304 6253
Fax
Email
dr.r.doroudian@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...